Phase 2 study of zanubrutinib (BGB-3111) in patients with relapsed/refractory marginal zone lymphoma (R/R MZL)
Opat, Stephen, Marcus, Robert, Portell, Craig Anthony, Reed, William, Co, Melannie, Huang, Jane, Trotman, Judith
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Benefit of rituximab maintenance after first-line bendamustine-rituximab in mantle cell lymphoma
Wang, Yucai, Larson, Melissa C., Kumar, Anita, Hill, Brian T, Bond, David Alan, Kahl, Brad S., Danilov, Alexey Valeryevich, Merryman, Reid, Grover, Natalie Sophia, Tun, Aung M., Ayyappan, Sabarish Ram, Pongas, Georgios, Portell, Craig Anthony, Munoz, Javier, Reagan, Patrick Michael, Alhaj Moustafa, Muhamad, Pophali, Priyanka Avinash, Greenwell, Irl Brian, Cohen, Jonathon Brett, Martin, Peter
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article